|
US 12,269,866 B2 |
|
| Compositions and methods for the treatment of carboxyhemoglobinemia |
| Mark T. Gladwin, Baltimore, MD (US); and Jesus Tejero Bravo, Pittsburgh, PA (US) |
| Assigned to University of Pittsburgh—Of the Commonwealth System of Higher Education, Pittsburgh, PA (US) |
| Filed by University of Pittsburgh—Of the Commonwealth System of Higher Education, Pittsburgh, PA (US) |
| Filed on Nov. 8, 2023, as Appl. No. 18/504,534. |
| Application 18/504,534 is a continuation of application No. 16/951,529, filed on Nov. 18, 2020, granted, now 11,845,785. |
| Application 16/951,529 is a continuation of application No. 16/557,168, filed on Aug. 30, 2019, granted, now 10,851,153, issued on Dec. 1, 2020. |
| Application 16/557,168 is a continuation of application No. 15/726,779, filed on Oct. 6, 2017, granted, now 10,421,800, issued on Sep. 24, 2019. |
| Application 15/726,779 is a continuation of application No. 14/776,363, abandoned, previously published as PCT/US2014/023180, filed on Mar. 11, 2014. |
| Claims priority of provisional application 61/834,035, filed on Jun. 12, 2013. |
| Claims priority of provisional application 61/799,155, filed on Mar. 15, 2013. |
| Prior Publication US 2024/0083979 A1, Mar. 14, 2024 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 14/795 (2006.01); A61K 9/00 (2006.01); A61K 38/00 (2006.01); A61K 38/41 (2006.01) |